Showing results (2461-2470 of 8,169) with videos related to
Sort By:
Pageof 817
Haematologica|March 1, 2013
Wiskott-Aldrich syndrome protein-deficient hematopoietic cells can be efficiently mobilized by granulocyte colony-stimulating factorSabine Charrier, Michael Blundell, Gregory Cédrone, et al.Haematologica|February 14, 2013
Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infantsEmma M C Driessen, Eddy H J van Roon, Jill A P Spijkers-Hagelstein, et al.Haematologica|June 5, 2013
Non-transfusion-dependent thalassemiasKhaled M Musallam, Stefano Rivella, Elliott Vichinsky, et al.Haematologica|June 12, 2013
Common variable immunodeficiency and idiopathic primary hypogammaglobulinemia: two different conditions within the same disease spectrumGertjan J Driessen, Virgil A S H Dalm, P Martin van Hagen, et al.Haematologica|June 12, 2013
Pediatric Acute Lymphoblastic Leukemia: Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemiaInge van der Sluis, Anja Möricke, Gabriele Escherich, et al.Haematologica|June 12, 2013
Platelet interaction with von Willebrand factor is enhanced by shear-induced clustering of glycoprotein IbαEelo Gitz, Charlotte D Koopman, Alèkos Giannas, et al.Haematologica|June 12, 2013
High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy programTamara Intermesoli, Alessandro Rambaldi, Giuseppe Rossi, et al.Haematologica|May 2, 2013
Principles of care for the diagnosis and treatment of von Willebrand diseaseGiancarlo Castaman, Anne Goodeve, Jeroen Eikenboom, et al.Haematologica|March 30, 2013
Insights into pathological mechanisms of missense mutations in C-terminal domains of von Willebrand factor causing qualitative or quantitative von Willebrand diseaseHamideh Yadegari, Julia Driesen, Anna Pavlova, et al.Haematologica|March 30, 2013
Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin's lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Ambroise Marcais, Raphael Porcher, Marie Robin, et al.Pageof 817